Yan Shi

47.9k total citations
75 papers, 1.9k citations indexed

About

Yan Shi is a scholar working on Molecular Biology, Cancer Research and Cognitive Neuroscience. According to data from OpenAlex, Yan Shi has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 34 papers in Cancer Research and 7 papers in Cognitive Neuroscience. Recurrent topics in Yan Shi's work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (23 papers) and Circular RNAs in diseases (22 papers). Yan Shi is often cited by papers focused on MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (23 papers) and Circular RNAs in diseases (22 papers). Yan Shi collaborates with scholars based in China, United States and Sweden. Yan Shi's co-authors include Wenkang Luan, Yongping You, Ning Liu, Yingyi Wang, Tao Tao, Xiaojian Li, Jin Qian, Junxia Zhang, Yun Xia and Ping Wang and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Yan Shi

71 papers receiving 1.9k citations

Peers

Countries citing papers authored by Yan Shi

Since Specialization

Citations

This map shows the geographic impact of Yan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shi more than expected).

Fields of papers citing papers by Yan Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shi. The network helps show where Yan Shi may publish in the future.

Co-authorship network of co-authors of Yan Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Shi. A scholar is included among the top collaborators of Yan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Shi. Yan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ecosystem service bundles under SSP-RCP and local scenarios: A pathway to comprehensive spatial planning for sustainability 2025 ·Resources Environment and Sustainability ·Shihao Zhou, (unknown), Yixiang Wang, (unknown), Yan Shi	3
2	Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer 2025 ·Cell Reports ·Chenchu Lin, (unknown), (unknown), (unknown), (unknown), (unknown), Yan Shi, Manoj Kushwaha, (unknown), Eduardo Salido, (unknown), (unknown), Peter D.A. Shepherd, Nora M. Navone, (unknown), Elizabeth M. Whitley, Michael Ittmann, Lívia S. Eberlin, Wenyi Wang, Daniel E. Frigo	0
3	Sinomenine Protects against Early Brain Injury by Inhibiting Microglial Inflammatory Response via Nrf2-Dependent Pathway after Subarachnoid Hemorrhage 2023 ·Brain Sciences ·(unknown), (unknown), (unknown), Xiang Li, (unknown), Youwu Fan, Yong Tang, Yan Shi, Ding Li, (unknown)	6
4	Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data 2022 ·Frontiers in Immunology ·(unknown), Ningjia Shen, Yan Shi, (unknown), Xiaohui Fu, Shuang Li, Bin Zhu, Wenlong Yu, Yongjie Zhang	79
5	Effect of differences in extubation timing on postoperative pneumonia following meningioma resection: a retrospective cohort study 2022 ·BMC Anesthesiology ·(unknown), Yan Shi, Jian Gao, Min Yu, Cunming Liu	1
6	LncRNA WEE2-AS1 Knockdown Inhibits the Proliferation, Migration and Invasion of Glioma Cells via Regulating miR-29b- 2-5p/TPM3 Axis 2021 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), (unknown), (unknown), Xiang Li, Yan Shi, (unknown), (unknown), Heming Wu	4
7	The COX10-AS1/miR-641/E2F6 Feedback Loop Is Involved in the Progression of Glioma 2021 ·Frontiers in Oncology ·Liang Liu, Xiaojian Li, Heming Wu, Yong Tang, Xiang Li, Yan Shi	9
8	Protective effects of Da-cheng-qi decoction in rats with intracerebral hemorrhage 2021 ·Phytomedicine ·Peng Zeng, Xiaoming Wang, (unknown), Teng Zhang, (unknown), Yan Shi, Shusheng Yang, Lin Li, Qing Tian	10
9	Protection of melatonin against acidosis‐induced neuronal injuries 2020 ·Journal of Cellular and Molecular Medicine ·Yan Shi, (unknown), Can Yang, (unknown), Peng Zeng, Xiaoming Wang, (unknown), (unknown), Qun Wang, Fuyuan Cao, Xinwen Zhou, Qing Tian	16
10	Avasimibe inhibits the proliferation, migration and invasion of glioma cells by suppressing linc00339 2020 ·Biomedicine & Pharmacotherapy ·Yidan Luo, Liang Liu, Xiaojian Li, Yan Shi	16
11	The long noncoding RNA FTX promotes a malignant phenotype in bone marrow mesenchymal stem cells via the miR-186/c-Met axis 2020 ·Biomedicine & Pharmacotherapy ·Liang Liu, Xiaojian Li, Yan Shi, Hua Chen	10
12	Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma 2019 ·Translational Cancer Research ·Wanwan Li, Chen Yang, (unknown), Yan Shi, Guanghai Dai, Xiaorong Li	6
13	Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22 2016 ·Oncotarget ·Wenkang Luan, (unknown), Yan Shi, Xuefeng Bu, Yun Xia, Jinlong Wang, (unknown), Xiaohui Liu, Yongping You, (unknown)	106
14	PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop 2016 ·Oncotarget ·Yan Shi, Tao Tao, Ning Liu, Wenkang Luan, Jin Qian, Rui Li, Qi Hu, Wei Yan, Junxia Zhang, Yongping You	20
15	Investigation and analysis of economic and family burden among patients with depression 2015 ·The Journal of practical nursing ·Yan Shi	2
16	Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations 2015 ·PLoS ONE ·Junfu Huang, Dong-zhu Zeng, Guangjie Duan, Yan Shi, Guohong Deng, Han Xia, Hanqing Xu, Na Zhao, Weiling Fu, Qing Huang	8
17	MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas 2015 ·Molecular and Cellular Biochemistry ·Jin Qian, Rui Li, Yingyi Wang, Yan Shi, Wenkang Luan, Tao Tao, Junxia Zhang, Yichang Xu, Yongping You	51
18	Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma 2014 ·Journal of Experimental & Clinical Cancer Research ·Rui Li, Kaiming Gao, Hui Luo, Xiefeng Wang, Yan Shi, (unknown), Wenkang Luan, Yongping You	51
19	[Expression of peroxisome proliferators-activated receptor in glioma and its effect on the growth of human glioma cells]. 2014 ·PubMed ·Yan Shi, Wenkang Luan, Tao Tao, Jiajia Wang, Jin Qian, (unknown), Ning Liu, Yongping You	2
20	Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas 2013 ·European Journal of Cancer ·Tao Tao, Yingyi Wang, Hui Luo, Lei Yao, Lin Wang, Jiajia Wang, Wei Yan, Junxia Zhang, Huibo Wang, Yan Shi, Yu Yin, Tao Jiang, Chunsheng Kang, Ning Liu, Yongping You	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact